Stephen R Marder

19PUBLICATIONS
112CO-AUTHORS
Molecular medicinePharmacogenomicsSensory processes, perception and performanceClinical neuropsychologyCentral nervous system
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (19)

|May 22, 2026
A Qualitative Investigation of the Experience of Taking Xanomeline and Trospium Chloride for Schizophrenia, Part 2: Perceived Changes in Subjective Quality of Life and Medication Satisfaction.

|Mar 23, 2026
A Qualitative Investigation of the Experience of Taking Xanomeline and Trospium Chloride for Schizophrenia, Part 1: Perceived Impact on Symptoms.

William P Horan, Cory Saucier, Peter J Weiden

|Apr 04, 2025
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Pimavanserin as an Adjunctive Treatment for the Negative Symptoms of Schizophrenia (ADVANCE-2) in Patients With Predominant Negative Symptoms.

Dragana Bugarski-Kirola, I-Yuan Liu, Celso Arango

|Feb 21, 2025
Considerations for Streamlining the Pathway Toward Approval of a Cognition Enhancer for Schizophrenia.

Keith H Nuechterlein, Michael F Green, Stephen R Marder

|Nov 06, 2024
Rationale and Challenges for a New Instrument for Remote Measurement of Negative Symptoms.

David Gordon Daniel, Alex S Cohen, Philip D Harvey

|Oct 08, 2024
Cognitive Impairment Associated With Schizophrenia: New Research Agenda.

Silvana Galderisi, Stephen R Marder

Pageof 4

Frequent Collaborators

2 joint publications

Anssi Solismaa

2 joint publications

Carina Ricciardi

2 joint publications

Patrik Švancer

2 joint publications

Niko Seppälä